16-68678827-C-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001793.6(CDH3):​c.612C>A​(p.Ile204Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 1,613,738 control chromosomes in the GnomAD database, including 17,409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2695 hom., cov: 32)
Exomes 𝑓: 0.14 ( 14714 hom. )

Consequence

CDH3
NM_001793.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -8.82

Publications

24 publications found
Variant links:
Genes affected
CDH3 (HGNC:1762): (cadherin 3) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. In addition, aberrant expression of this protein is observed in cervical adenocarcinomas. Mutations in this gene are associated with hypotrichosis with juvenile macular dystrophy and ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome (EEMS). [provided by RefSeq, Nov 2015]
CDH3 Gene-Disease associations (from GenCC):
  • EEM syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital hypotrichosis with juvenile macular dystrophy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 16-68678827-C-A is Benign according to our data. Variant chr16-68678827-C-A is described in ClinVar as Benign. ClinVar VariationId is 320227.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.82 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.283 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH3NM_001793.6 linkc.612C>A p.Ile204Ile synonymous_variant Exon 6 of 16 ENST00000264012.9 NP_001784.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH3ENST00000264012.9 linkc.612C>A p.Ile204Ile synonymous_variant Exon 6 of 16 1 NM_001793.6 ENSP00000264012.4

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26292
AN:
151992
Hom.:
2694
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.287
Gnomad AMI
AF:
0.164
Gnomad AMR
AF:
0.104
Gnomad ASJ
AF:
0.116
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0774
Gnomad FIN
AF:
0.165
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.143
Gnomad OTH
AF:
0.168
GnomAD2 exomes
AF:
0.126
AC:
31744
AN:
251260
AF XY:
0.124
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.0730
Gnomad ASJ exome
AF:
0.114
Gnomad EAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.176
Gnomad NFE exome
AF:
0.144
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.135
AC:
197528
AN:
1461628
Hom.:
14714
Cov.:
34
AF XY:
0.133
AC XY:
96961
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.296
AC:
9903
AN:
33474
American (AMR)
AF:
0.0780
AC:
3490
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.114
AC:
2981
AN:
26132
East Asian (EAS)
AF:
0.000554
AC:
22
AN:
39680
South Asian (SAS)
AF:
0.0757
AC:
6529
AN:
86258
European-Finnish (FIN)
AF:
0.173
AC:
9234
AN:
53370
Middle Eastern (MID)
AF:
0.124
AC:
716
AN:
5768
European-Non Finnish (NFE)
AF:
0.141
AC:
156542
AN:
1111840
Other (OTH)
AF:
0.134
AC:
8111
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
9659
19317
28976
38634
48293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5518
11036
16554
22072
27590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26328
AN:
152110
Hom.:
2695
Cov.:
32
AF XY:
0.169
AC XY:
12594
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.287
AC:
11921
AN:
41468
American (AMR)
AF:
0.104
AC:
1586
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
404
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5170
South Asian (SAS)
AF:
0.0774
AC:
373
AN:
4818
European-Finnish (FIN)
AF:
0.165
AC:
1752
AN:
10598
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.143
AC:
9730
AN:
67978
Other (OTH)
AF:
0.168
AC:
353
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1095
2191
3286
4382
5477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.144
Hom.:
4066
Bravo
AF:
0.174
Asia WGS
AF:
0.0610
AC:
213
AN:
3478
EpiCase
AF:
0.143
EpiControl
AF:
0.143

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

EEM syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
2.6
DANN
Benign
0.70
PhyloP100
-8.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8049247; hg19: chr16-68712730; COSMIC: COSV50577794; API